# ASSURE Study - Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICD Implantations

> **NCT00231426** · PHASE4 · COMPLETED · sponsor: **Boston Scientific Corporation**

## Conditions studied

- Tachyarrhythmia

## Interventions

- **DEVICE:** ICD

## Key facts

- **NCT ID:** NCT00231426
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** — (—)
- **Last updated:** 2006-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00231426

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00231426, "ASSURE Study - Arrhythmia Single Shock DFT Versus ULV: Risk Reduction Evaluation With ICD Implantations". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00231426. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*